Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.1182367-47-0
RAD140 Basic information |
Product Name: | RAD140 |
Synonyms: | RAD140;2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile |
CAS: | 1182367-47-0 |
MF: | |
MW: | 0 |
EINECS: | |
Product Categories: | SARMs(Selective androgen receptor modulator) |
Mol File: | Mol File |
|
RAD140 Chemical Properties |
Safety Information |
RAD140 Usage And Synthesis |
RAD140 Preparation Products And Raw materials |
RAD140 Basic information |
Product Name: | RAD140 |
Synonyms: | RAD140;2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile |
CAS: | 1182367-47-0 |
MF: | |
MW: | 0 |
EINECS: | |
Product Categories: | SARMs(Selective androgen receptor modulator) |
Mol File: | Mol File |
|
RAD140 Chemical Properties |
Safety Information |
RAD140 Usage And Synthesis |
RAD140 Preparation Products And Raw materials |
Product Name | RAD-140 |
Appearance | White Powder |
CAS NO. | 118237-47-0 |
Purity | >99% |
Shelf life | 2 years |
RAD140 is a nonsteroidal selective androgen receptor modulator, or SARM, that resulted from an internal drug discovery program that began in 2005. RAD140 has demonstrated potent anabolic activity on muscle and bone in preclinical studies and has completed 28-day preclinical toxicology studies in both rats and monkeys. Because of its high anabolic efficacy, receptor selectivity, potent oral activity and long duration half-life, we believe that RAD140 has clinical potential in a number of indications where the increase in lean muscle mass and/or bone density is beneficial, such as treating the weight loss due to cancer cachexia, muscle frailty and osteoporosis.